Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance ...
The medical-device maker beats quarterly earnings expectations but offers a disappointing outlook for the current quarter.
On Wednesday, Boston Scientific experienced a loss of nearly one-fifth of its market capitalization in a single trading ...
Core Scientific provides blockchain infrastructure and digital asset mining for institutional and enterprise clients in North ...
Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss ...
Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.
Boston Scientific Corporation (NYSE: BSX) reported Q4 2025 revenues of $5.29B, beating management guidance and consensus estimate.
After 25 years, Brookhaven National Laboratory’s Relativistic Heavy Ion Collider—the U.S.’s largest particle collider—has ...
View Boston Scientific Corporation BSX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results